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Introduction
Diabetes mellitus is considered to be a ‘cardiovascular disease 
equivalent’ causing various vascular complications.
1) Endothelial 
dysfunction is widely observed in diabetes mellitus, which results in 
various cardiovascular complications. In diabetes, endothelial dys-
function is characterized by a reduced availability of endothelium-
derived vasodilating factors, such as nitric oxide.
2)3) Impaired endo-
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thelium-dependent vasodilation has been demonstrated in patients 
with type 1 and 2 diabetes
4)5) as well as in different animal models 
of diabetes.
3)6) Moreover, endothelial dysfunction is induced after 
relatively short periods of high glucose treatment.
7) In the natural 
history of type 2 diabetes, endothelial dysfunction is even consid-
ered to predate the onset of hyperglycemia.
8) 
Recently, Krüppel-like factor 2 (KLF2) has been reported to play an 
important role in the maintenance of endothelial function. KLF2 af-
fects the expression of various vasoprotective molecules including 
endothelial nitric oxide synthase (eNOS) that confers anti-inflamma-
tory, anti-thrombotic, and anti-proliferative effects.
9) During the in-
vestigation of KLF2, we found that KLF2 contains forkhead factor 
binding motifs in its promoter region.
10) This was of interest because 
dysregulated, chronic FOXO1 activation with prolonged hyperglyce-
mia was suggested to cause pancreatic β-cell failure and hypergly-
cemia in type 2 diabetes.
11)12) The presence of the forkhead factor 
binding motifs in the KLF2 promoter region and its observed func-
tion in endothelial cells led to the hypothesis that KLF2 may be sup-
pressed under hyperglycemic conditions and that this phenome-
non may be regulated by FOXO1. In this study, we evaluated the 240  KLF2 Suppression in Diabetes
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expression of KLF2 in endothelial cells cultured in high glucose and 
investigated its functional implication in a diabetic animal model.
Subjects and Methods
Endothelial cell culture
Four to six passage human umbilical vein endothelial cells (HUVECs, 
Lonza) were plated onto 2% gelatin-coated dishes (Sigma) and 
maintained in EGM kit (Lonza). HUVECs were cultured using various 
concentrations of glucose. For shear stress experiments, confluent 
HUVECs were exposed to unidirectional laminar flow using an or-
bital shaker (FinePCR co. SH30).
Reverse transcriptase-polymer chain reaction, immunoblot 
and immunofluorescent staining
Changes in ribonucleic acid (RNA) expression of eNOS, FOXO1, and 
KLF2 were determined by reverse transcriptase-polymer chain reac-
tion (RT-PCR) as previously described.
13) Primers used were: eNOS 
(forward primer: 5`-CCA GCT AGC CAA AGT CAC CAT-3; reverse 
primer: 5`-GTC TCG GAG CCA TAC AGG ATT-3`), FOXO1 (forward 
primer: 5`-GAA GAC ACC TGT ACA AGT GCC-3; reverse primer: 5`-
CTG CTT CTC TCA GTT CCT GCT-3`), KLF2 (forward primer: 5`-CGG 
CAA GAC CTA CAC CAA GAG-3; reverse primer: 5`-CGC ACA GAT 
GGC ACT GGA AT-3`), and GAPDH (forward primer: 5`-CGT GGA 
AGG ACT CAT GAC-3; reverse primer: 5`-CAA ATT CGT TGT CAT ACC 
AG-3`). Total RNAs were isolated by the Trizol (Invitrogen) method, 
reverse-transcribed with a reverse transcription system (Promega), 
and amplified with primers for each molecule and GAPDH.
Immunoblot analysis was performed by modification of the pro-
tocol described in our previous work.
13) The primary antibodies used 
were: anti-KLF2 (Santa Cruz Biotechnology, Inc.), anti-FOXO1 (Santa 
Cruz Biotechnology, Inc.), anti-eNOS (Santa Cruz Biotechnology, Inc.) 
and anti-α-tubulin (Oncogene). As a secondary antibody, anti-mouse 
IgG HRP (Molecular Probes) or anti-rabbit IgG HRP (Molecular Pro-
bes) was used at a dilution of 1:2000. 
Small interfering ribonucleic acid for FOXO1 blocking
For the blockage of FOXO1, siFOXO1 (Samchully Pharm. Co., Ltd., 
Korea) was used. Control small interfering ribonucleic acid (siRNA) 
was purchased from Santa Cruz Biotechnology. SiRNA (30 nM) was 
transfected to HUVECs at room temperature with the use of Meta-
fectene Pro (Bionex). 
Animal preparation, immunohistochemical staining and 
carotid ligation
The experimental protocol was designed in accordance with the 
Guide for Experimental Animal Research issued by the Laboratory 
for Experimental Animal Research, Clinical Research Institute, Uni-
versity Hospital. The Otsuka Long Evans Tokushima Fatty (OLETF) 
strain of rat is an excellent model for obese type II diabetes, char-
acterized by hypertension, hypertriglyceridemia, hyperinsulinemia, 
hyperglycemia, insulin resistance, and abundant visceral fat with 
100% affected by diabetes by 25 weeks.
14) Their lean littermates 
were Long Evans Tokushima Otsuka (LETO) rats. Male OLETF rats and 
LETO rats (6 weeks old) were a gift from Otsuka Pharmaceuticals 
(Tokushima, Japan). We started the animal experiment with 5 rats 
in each group, however, one of each group died during the experiment. 
Therefore, final analysis was performed in 4 rats in each group.
For immunostaining of KLF2, the abdominal aortic rings harvest-
ed at the celiac trunk bifurcating levels were treated with 3% H2O2, 
washed with phosphate buffered saline, blocked with 1.5% horse 
serum, and followed by incubation with a goat-anti-KLF2 antibody 
(Santa Cruz Biotechnology, Inc.), biotinylated secondary antibody 
against goat IgG (Vector Laboratories), avidin DH, and biotinylated 
horseradish peroxidase H reagents (Vectastain ABC reagents, Vector 
Laboratories). Hematoxylin and eosin staining was used to reveal 
the cell nuclei and cytoplasm. The results were examined by light 
microscopy, and images were acquired using a digital camera. For the 
induction of vascular remodeling, rats were anesthetized with a 
mixture of ketamine and xylazine and maintained at 37°C. Blood 
flow in the left common carotid artery was reduced by partial liga-
tion of the left external and internal carotid arterial branches as pre-
viously described.
15) The branches of the right carotid artery were ex-
posed but not ligated (sham operation). The animals were allowed 
to recover for 7 days and then sacrificed. Both carotid artery branch-
es were harvested and embedded in paraffin. Cross sections (4 µm) 
were processed with hematoxylin/eosin and analyzed by use of MCID 
image software (Imaging Research Inc) as described previously.
16)
Statistical analysis 
We expressed data as mean±SEM. The unpaired 2-tailed t-test 
between the two groups and analysis of variance for multiple com-
parisons was used to compare continuous variables. Statistical com-
parisons of continuous variables between ligation-operated and 
sham-operated arteries were performed using a paired t-test for 
comparison for intra-group comparisons and a Student’s t-test for 
inter-group comparisons. All calculations were performed using Sta-
tistical Package for the Social Sciences (SPSS) 13.0 (SPSS Inc.). P< 
0.05 was considered statistically significant. 
Results
Krüppel-like factor 2 was suppressed in high glucose condition
First, we cultured HUVECs at high concentrations of glucose 241 Hae-Young Lee, et al.
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ranging from 5 mM to 100 mM. We observed no changes of cell 
viability until day 3 by 35 mM of glucose. However, above 60 mM 
glucose cytopathic change was observed. Therefore, we determin-
ed 35 mM as physiologically high glucose for further experiments 
(Fig. 1).
Krüppel-like factor 2 expression significantly decreased in high 
glucose conditions in a dose-dependent manner, and eNOS ex-
pression was also suppressed (Fig. 2A and C). Then, we serially 
evaluated the expression of FOXO1 and KLF2 under physiologically 
high glucose conditions. FOXO1 became unphosphorylated, where-
as there was no change in the total FOXO1 amount, which indicat-
ed that it was activated. In contrast, KLF2 was almost completely 
diminished from 6 hours after glucose treatment (p<0.05) (Fig. 2B 
and D).
Fig. 1. Morphologic changes of HUVECs 72 hours after culture under high glucose conditions. HUVECs were cultured in high glucose with the indicated 
concentration. HUVECs: human umbilical vein endothelial cells. 
Fig. 2. Activation of FOXO1 and inhibition of KLF2 under high glucose conditions. A: KLF2 and eNOS protein expression at the indicated concentration of 
glucose. B: serial immunoblot analysis of phosphorylated FOXO1 on serine 256 (p-FOXO1), total FOXO1 (t-FOXO1), and KLF2 expression in endothelial cells 
incubated under physiologically high glucose conditions (35 mM). C: quantification of triplicate experiments of A by densitometry. D: quantification of 
triplicate experiments of B by densitometry. *p<0.05 compared to the control, 
†p<0.05 compared to the value of 36 hours. KLF2: Krüppel-like factor 2, 
eNOS: endothelial nitric oxide synthase. 
1.5
1.0
0.5
0.0
1.5
1.0
0.5
0.0
2.5
2.0
1.5
1.0
0.5
0.0
2.0
1.5
1.0
0.5
0.0
*
*
* *
*
*
* *
* * *
*
†
†
†
† † † †
*
*
KLF2 eNOS
         -                    35                50               100     Glucose (mM)     0            3          6        12         24        36         3          6         12         24       36   Time (hours)
35 mM glucose
KLF2
eNOS
α-tubulin
p-FOXO1a
t-FOXO1a
KLF2
α-tubulin
p-FOXO1a KLF2
G
5
 
m
M
G
3
5
 
m
M
G
5
0
 
m
M
G
1
0
0
 
m
M
G
5
 
m
M
G
3
5
 
m
M
G
5
0
 
m
M
G
1
0
0
 
m
M
0
3
6
1
2
2
4
3
6
G
3
G
6
G
1
2
G
2
4
G
3
6
0
3
6
1
2
2
4
3
6
G
3
G
6
G
1
2
G
2
4
G
3
6
A  
C  
B  
D  242  KLF2 Suppression in Diabetes
http://dx.doi.org/10.4070/kcj.2012.42.4.239 www.e-kcj.org
Shear flow induced Krüppel-like factor 2 expression was 
inhibited under high glucose conditions
Next, we evaluated the effect of high glucose under shear stress, 
which is one of the main physiologic stimuli of KLF2.
9) A total of 12 
dynes/cm
2 of shear stress was applied for 24 hours using an orbital 
shaker. HUVECs exposed to the shear stress aligned following the 
flow direction, validating that shear stress was adequately applied 
(Fig. 3A). Shear stress induces KLF2 in HUVECs, followed by eNOS ac-
tivation. However, both KLF2 and eNOS were significantly reduced 
with high glucose even under shear stress conditions (Fig. 3B). 
Krüppel-like factor 2 suppression by high glucose was 
mediated by FOXO1
Because KLF2 has the forkhead factor binding motifs in its pro-
moter sequences and its suppression in high glucose was tempo-
rally well correlated with FOXO1 activation, we evaluated the role 
of FOXO1 in KLF2 regulation. When we inhibited FOXO1 by siRNA, 
KLF2 expression, which was suppressed in high glucose, recovered to 
a greater extent than the basal status. eNOS expression also recov-
ered by FOXO1 siRNA and correlated with the expression pattern 
of KLF2 (Fig. 4).
Krüppel-like factor 2 was suppressed in the vessels 
of diabetic rats
In order to confirm our in vitro findings, we performed the animal 
experiment using OLETF rats as animal models of insulin resistant, 
type 2 diabetes. As compared to control LETO rats, the OLETF rats 
showed more than two-fold higher serum glucose levels. In addi-
Fig. 3. Inhibition of shear flow-induced KLF2 expression under high glucose conditions. A: morphologic changes in HUVECs after shear stress application 
(24 hours, 12 dynes/cm
2). B: immunoblot analysis evaluating the impact of shear stress and high glucose on the expression of KLF2 and eNOS. KLF2: Krüp-
pel-like factor 2, HUVECs: human umbilical vein endothelial cells, eNOS: endothelial nitric oxide synthase.
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Fig. 4. Suppression of KLF2 and eNOS by FOXO1 in endothelial cells. A: representative RT-PCR analysis figure evaluating blocking effect of FOXO1 by 
FOXO1 siRNA on KLF2 and eNOS mRNA expression in high glucose condition. B-D: quantification of triplicate experiments of A. *p<0.05 compared to the 
control. KLF2: Krüppel-like factor 2, eNOS: endothelial nitric oxide synthase, RT-PCR: reverse transcriptase-polymer chain reaction, siRNA: small interfering 
ribonucleic acid, mRNA: messenger ribonucleic acid.
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tion, the body weight was also significantly greater in the OLETF rats 
than in the LETO rats. The serum triglyceride and total cholesterol 
levels in the OLETF rats were significantly higher than those of the 
LETO rats (Table 1). As was consistent with in vitro findings, KLF2 
expression in the carotid arteries of the OLETF rats was significant-
ly reduced compared to those of the control LETO rats (Fig. 5). 
Next, we evaluated the expression of KLF2 at the branching point 
(bifurcation point) between the abdominal aorta and the celiac ar-
tery of the indicated rats. In the flow-dividing side of the bifurcation 
point of abdominal aorta, where the shear stress is high and more la-
minar, the expression level of KLF2 was reported to be more promi-
nent compared to the lateral side (Fig. 6A).
17) In the OLETF rats, KLF2 
expression at the luminal lining was confined to the flow-dividing 
side of the bifurcation point and its circumference of expression 
was smaller than in the LETO rats (Fig. 6B and C). 
Neointimal formation augmented in diabetic rats 
In this carotid artery ligation mouse model, neointimal formation 
was reported to occur in association with reduced luminal area at 
the proximal portion of the ligated site.
15) In the non-ligated contra-
lateral side of carotid artery, there were no significant differences 
in intima/media ratio between OLETF rats and the control LETO rats. 
However, in the ligated side, the neointimal area significantly in-
creased in OLETF rats compared to control LETO rats 1 week after the 
ligation (Fig. 7). 
Discussion
The major finding of our study was that KLF2 was suppressed 
under high glucose conditions. This study also had several addi-
tional, novel findings. First, FOXO1 in ECs was activated under high 
glucose conditions, which could mediate KLF2 suppression. Second, 
this suppression of KLF2 was followed by the suppression of its 
important downstream molecule, eNOS. Third, by using the OLETF 
rats as animal models of insulin resistant type 2 diabetes, we sh-
Table 1. Comparison of body weight and blood chemistry between OLETF 
and control LETO rats
LETO rats (n=4) OLETF rats (n=4) p
Body weight (g) 450±26 512±15 <0.001
Glucose (mg/dL) 231±17 431±125 <0.001
Cholesterol (mg/dL) 95±2 171±23 <0.001
Triglyceride (mg/dL) 102±10 447±79 <0.001
HDL (mg/dL) 34±1 54±5 <0.001
LETO: Long Evans Tokushima Otsuka, OLETF: Otsuka Long Evans Tokushima 
Fatty, HDL: high density lipoprotein
Fig. 5. Suppression of KLF2 in the blood vessels from diabetic, OLEFT rats. 
Representative immunofluorescent microscopic images of carotid arteries 
stained with KLF2 (colored-red) in the OLETF rats (left) and the control LETO 
rats (right). KLF2: Krüppel-like factor 2, OLEFT: Otsuka Long Evans Tokushi-
ma Fatty, LETO:  Long Evans Tokushima Otsuka.
LETO  OLETF
Fig. 6. Comparison of KLF2 expression in endothelial cells at abdominal-celiac branch point between OLETF and control LETO rats. A: schematic showing 
the branch point of the celiac artery off the abdominal aorta. The line shows the section through which the samples were taken for immunohistochemical 
examination of KLF2 expression. B: representative photographs of immunofluorescent staining of blood vessels with KLF2 in the OLETF rats and the LETO 
rats. KLF2 expression is stained red at the branching point between the abdominal aorta and the celiac artery of the indicated rats. Arrow indicates ‘athero-
sclerosis-resistant flow-dividing’ side and ‘atherosclerosis-prone lateral’ side. C: semi-quantitative graph of KLF2-stained luminal circumferential length (4 
rats in each group). KLF2: Krüppel-like factor 2, OLEFT: Otsuka Long Evans Tokushima Fatty, LETO:  Long Evans Tokushima Otsuka.
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owed these in vitro findings could be extrapolated to an in vivo sit-
uation. Finally, we showed that this suppression of KLF2 in OLETF 
rats may increase neointimal formation as well as intraluminal th-
rombus formation. 
Endothelial dysfunction is regarded as an initial critical mecha-
nism of vascular damage in various cardiovascular diseases includ-
ing diabetes. In diabetes, endothelial dysfunction is characterized 
by decreased eNOS activity.
2) KLF2 is regarded as the main and most 
potent inducer of eNOS expression. Here we showed that KLF2 ex-
pression was markedly suppressed in high glucose. Moreover, we 
found for the first time that FOXO1 activated by high glucose is a 
negative transcriptional regulator of KLF2 leading to suppression 
of eNOS expression and vascular dysfunction in a diabetic animal 
model. This high glucose-FOXO1-KLF2 pathway may exert more pro-
found effects in diabetic vasculopathy considering that even near-
ly half of the flow-regulated genes are dependent on KLF2.
18) 
In this study, we intended to evaluate the functional implication 
of KLF2 suppression via the induction of vascular remodeling in 
vivo. We assessed the change of KLF2 expression at the bifurcation 
point between abdominal aorta and celiac trunk, because this lo-
cation has both the ‘atherosclerosis-resistant flow-dividing side’ 
with high shear stress and the ‘atherosclerosis-prone lateral side’ 
with disturbed low shear stress, and thus is good for observation 
of KLF2 expression change.
17) In the diabetic animal model, KLF2 
expression significantly decreased, which was only maintained at 
the flow-dividing side. This implicated that the resistance to turbu-
lent flow at the bifurcation region may be impaired in diabetes. Mo-
reover, one case of total carotid occlusion with thrombus was ob-
served in the OLETF rat group. Of course, we cannot make a definitive 
conclusion with only this one case, but considering the anti-throm-
botic effect of KLF2/eNOS, it seemed to be a very relevant finding. 
The main limitation of this study is that we did not present the 
data of specific replenishing experiments of KLF2 in diabetic rats due 
to the lack of lentiviral vector. However, the findings of this study 
do suggest that KLF2 suppression, at least partially, may be responsi-
ble for impaired endothelial function in a diabetic condition. 
The findings of this study are in accordance with many previous 
clinical findings in diabetic patients. In diabetic patients, even with-
out preclinical or clinical atherosclerosis, endothelial function is al-
ready disturbed.
19) Also, the prevalence of complex coronary lesions, 
such as bifurcation lesions, is more than two fold higher in diabetic 
patients.
20) In addition, despite intervention with stents, diabetic pa-
tients have a greater than three times higher risk of stent thrombo-
sis and major adverse cardiac events.
21) KLF2 suppression under high 
glucose conditions may be a possible mechanism that explains the 
pathogenesis of such diabetic vascular complications. 
Lastly, the findings of this study can have clinical implications on 
adopting the KLF2 replenishing strategy in diabetic patients for pre-
venting diabetic vascular dysfunction. For example, KLF2 has re-
cently been reported to be induced by several 3-hydroxy-3-meth-
ylglutaryl coenzyme A reductase inhibitors (statins) independent of 
its cholesterol lowering capacity.
22-24) In this aspect, the findings of 
this study suggest the implication of intensive statin treatment in 
preventing diabetic vascular dysfunction. Another promising strat-
egy is exercise training which can increase shear flow through the 
vessel lumen, subsequently introducing the physiologically rele-
vant stimulus that augments endothelial KLF2 expression.
25) 
In conclusion, KLF2 suppression in endothelial cells by high glu-
cose is a plausible mechanism of diabetic endothelial dysfunction. 
Therefore, the strategy of replenishing KLF2 may be effective for 
Fig. 7. Evaluation of neointimal formation after induction of vascular remodeling. A: representative photomicrographs of common carotid arteries sec-
tions from the indicated rats 1 week after ligation. At the left are photographs from the sham-operated artery. At the right are photographs from the liga-
tion-operated artery. Yellow arrow indicates intima. B: comparison of intimal thickness. n=8 (two slide sections in one carotid artery sample) in each group 
(4 rats in each group). Statistical comparisons between ligation-operated and sham-operated arteries were performed using a paired t-test for comparison for 
intra-group comparisons and a Student’s t-test for inter-group comparisons. OLEFT: Otsuka Long Evans Tokushima Fatty, LETO:  Long Evans Tokushima Otsuka.
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preventing diabetic vascular dysfunction. 
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